Prothymosin Alpha
Immune & Anti-InflammatoryAlso known as: ProTα, PTMA, Prothymosin-α
Mechanism
Prothymosin alpha is a small nuclear protein found in virtually every cell in the body but concentrated in thymic tissue. Unlike most immune peptides that work from outside the cell, prothymosin alpha functions inside the nucleus where it helps control gene expression related to cell proliferation and immune regulation. It enhances the activity of natural killer cells, promotes T-cell maturation, and has shown anti-tumor effects in preclinical studies. It is also studied for its unique ability to protect cells from death (anti-apoptotic) after ischemic injury.
Technical detail
Prothymosin alpha (ProTα) is a 109-amino-acid intrinsically disordered nuclear protein encoded by the PTMA gene. Abundant in thymus — expression correlates with cell proliferation rate. Mechanisms: (1) Nuclear — interacts with histone H1, remodeling chromatin structure to facilitate transcription; binds CREB-binding protein (CBP), modulating gene expression; inhibits the apoptosome by sequestering cytochrome c and Apaf-1 in the cytoplasm; (2) Extracellular immune functions — when released (necrosis or active secretion), activates TLR4 on dendritic cells as a damage-associated molecular pattern (DAMP), triggering MyD88/NF-κB signaling and DC maturation; enhances NK cell cytotoxicity via IFN-γ induction; promotes MHC class I antigen presentation; (3) Neuroprotective — prevents ischemic neuronal death in animal stroke models by inhibiting apoptosome assembly. Studied as anti-cancer immunoadjuvant (enhanced response to HCC treatment in Phase I/II, Cordero et al.). The C-terminal fragment (ProTα100-109) retains immune stimulatory activity.